Radcliffe Capital Management, L.P. - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 33 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$672,317
+1.7%
66,566
-0.2%
0.02%
+31.2%
Q3 2022$661,000
+1.2%
66,6660.0%0.02%
+6.7%
Q2 2022$653,000
+0.3%
66,6660.0%0.02%0.0%
Q1 2022$651,000
+0.6%
66,6660.0%0.02%
-11.8%
Q4 2021$647,000
-0.3%
66,6660.0%0.02%
-10.5%
Q3 2021$649,000
+0.3%
66,6660.0%0.02%
-5.0%
Q2 2021$647,00066,6660.02%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Tyrus Capital S.A.M. 133,332$39,7330.09%
ANGELO GORDON & CO., L.P. 13,333$134,6630.02%
Radcliffe Capital Management, L.P. 66,566$672,3170.02%
Dryden Capital, LLC 15,000$4,4700.01%
METEORA CAPITAL, LLC 50,000$14,9000.00%
Arena Capital Advisors, LLC- CA 19,251$5,7370.00%
MMCAP International Inc. SPC 73,525$21,9100.00%
PERISCOPE CAPITAL INC. 196,896$57,5710.00%
MARSHALL WACE, LLP 36,056$364,1650.00%
CLEAR STREET LLC 217,000$650.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders